| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 11/02/2006 | CA2609633A1 Nicotinamide riboside compositions |
| 11/02/2006 | CA2606222A1 Reagents that bind ccx-ckr2 |
| 11/02/2006 | CA2606102A1 Modulation of antibody effector function by hinge domain engineering |
| 11/02/2006 | CA2606088A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 11/02/2006 | CA2606002A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns |
| 11/02/2006 | CA2605924A1 Recombinant flavivirus vaccines |
| 10/31/2006 | US7129397 Promoters functional in plant plastids |
| 10/31/2006 | US7129395 nucleotide sequence that code polypeptides having 3-oxoacyl-[acyl carrier protein] reductase (OAR) activity; biosynthesis of polylactones in transformed plants and host cells |
| 10/31/2006 | US7129346 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 10/31/2006 | US7129344 Nucleic acid isolation |
| 10/31/2006 | US7129343 Enhancing transcription via TATA Box census element as core of promoter |
| 10/31/2006 | US7129342 Infectious cDNA clone of GB virus B and uses thereof |
| 10/31/2006 | US7129341 Identification of Candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 10/31/2006 | US7129340 Point mutations; recombinant vectors/molecular targets; transcription factors |
| 10/31/2006 | US7129339 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
| 10/31/2006 | US7129335 For cleaving and sequencing polysaccharides such as glycosaminoglycans, removing polysaccharides from solution, inhibiting anticoagulant activity, inhibiting angiogenesis, treating cancer, inhibiting maternal malarial infection |
| 10/31/2006 | US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof |
| 10/31/2006 | US7129308 Functionalized silicon compounds and methods for their synthesis and use |
| 10/31/2006 | US7129307 Functionalized silicon compounds and methods for their synthesis and use |
| 10/31/2006 | US7129223 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference |
| 10/31/2006 | US7129211 Adipocyte Insulin adpinsl with Insulin A and B chains and an effective method of treating type 2 diabetes in a subject using adipocyte insulin |
| 10/31/2006 | US7129089 Annexin and P34 promoters and use in expression of transgenic genes in plants |
| 10/31/2006 | US7129085 Polynucleotides encoding a human leucine-rich repeat domain containing protein, HLLRCR-1 |
| 10/31/2006 | US7129083 PiggyBac transformation system |
| 10/31/2006 | US7129078 DNA encoding androgen receptor fragment |
| 10/31/2006 | US7129074 Nucleoside triphosphate diphosphohydrolase (NTPDase 8) and uses thereof |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7129066 Nucleotide sequences coding for the citE gene |
| 10/31/2006 | US7129063 Junction-enriched and -associated protein (JEAP); antibodies for visualizing localization |
| 10/31/2006 | US7129062 Matrix attachment regions and methods for use thereof |
| 10/31/2006 | US7129060 Export systems for recombinant proteins |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7129049 detecting the presence of a biomarker; presence of A nucleotides at nucleotide 102 in both alleles is indicative of the horse being predisposed to or has GSD IV |
| 10/31/2006 | US7129048 Identifying preferential nucleotide sequences using coded microcrystal microarrays; gene pattern expression analysis; semiconductors and bioassays |
| 10/31/2006 | US7129047 Gold bonded to Dna as detector; measuring fluorescence; concave, convex pattern on surface |
| 10/31/2006 | US7129046 Linking to chemical array assemblies with metal layers |
| 10/31/2006 | US7129045 Methods of detecting polynucleotide kinase and its use as a label |
| 10/31/2006 | US7129043 upregulation of the CLN3 gene in subject identifies the subject as having an increased risk of developing colon cancer |
| 10/31/2006 | US7129041 Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome |
| 10/31/2006 | US7128910 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2256545C Probe for analysis of nucleic acids |
| 10/31/2006 | CA2179012C Molecular diagnosis of familial adenomatous polyposis |
| 10/26/2006 | WO2006113277A2 Multivalent soluble tyrokinase receptor that bind angiogenic factor |
| 10/26/2006 | WO2006113198A2 Methods of enhancing isolation of rna from biological samples |
| 10/26/2006 | WO2006112818A2 3' modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
| 10/26/2006 | WO2006112737A1 Vesiculins |
| 10/26/2006 | WO2006060598A3 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN AND INTERLEUKIN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/26/2006 | WO2006022882A3 Canine pancreatic lipse |
| 10/26/2006 | WO2006015376A3 Monocot ahass sequences and methods of use |
| 10/26/2006 | WO2006010033A3 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 10/26/2006 | WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 10/26/2006 | WO2005086938A3 Artificial mutation controls for diagnostic testing |
| 10/26/2006 | WO2005054427A3 Target sequences for synthetic molecules |
| 10/26/2006 | WO2005035719A3 Modified luciferase |
| 10/26/2006 | WO2002090522A3 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 10/26/2006 | WO2002078420A3 Molecules for disease detection and treatment |
| 10/26/2006 | US20060242739 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 10/26/2006 | US20060242737 Modulation of flowering time by the pft1 locus |
| 10/26/2006 | US20060242736 Dissimilar promoters for gene suppression |
| 10/26/2006 | US20060242732 encode pesticidal proteins; transgenic pest resistant plants |
| 10/26/2006 | US20060242729 Polynucleotides encoding proteins involved in plant metabolism |
| 10/26/2006 | US20060242725 for importing nucleic acids, such as DNA, into the nuclei of osteoblast lineage cells (the bone forming cells of the skeleton) |
| 10/26/2006 | US20060242724 Receptor |
| 10/26/2006 | US20060242721 Gene families associated with liver cancer |
| 10/26/2006 | US20060242719 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in gentic transformation technology |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060241284 Transmembrane protein amigo and uses thereof |
| 10/26/2006 | US20060241075 Moderating Desmoglein gene expression |
| 10/26/2006 | US20060241072 Oligomeric compounds for use in gene modulation |
| 10/26/2006 | US20060241070 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treament of cancer |
| 10/26/2006 | US20060241069 Treatment of hyperproliferative disease |
| 10/26/2006 | US20060241068 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease |
| 10/26/2006 | US20060241039 reduce blood clotting activity by reducing thrombin generation; thrombotic diseases |
| 10/26/2006 | US20060241033 Markers for pre-cancer and cancer calls and the method to interfere with cell proliferation therein |
| 10/26/2006 | US20060241015 Cancer genes |
| 10/26/2006 | US20060240537 Isolated nucleic acid sequence encoding plant acid phosphatase |
| 10/26/2006 | US20060240535 Carbonyl reductase from lactococcus lactis |
| 10/26/2006 | US20060240533 Assembly for the stabilisation of vertebral bodies of the spine |
| 10/26/2006 | US20060240532 Amplification, translation, transcription |
| 10/26/2006 | US20060240526 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240523 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 10/26/2006 | US20060240521 DNA sequences for regulating transcription |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 10/26/2006 | US20060240510 Method for designing peptides |
| 10/26/2006 | US20060240502 GTP cyclohydrolase II as a target for fungicides |
| 10/26/2006 | US20060240472 Pigment protein |
| 10/26/2006 | US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product |
| 10/26/2006 | US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/26/2006 | US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 10/26/2006 | US20060240459 ClCKb mutation as a diagnostic and therapeutical target |
| 10/26/2006 | US20060240455 Oxazine derivatives |
| 10/26/2006 | US20060240452 Flourecent quinacridone derivatives |